Atlas Trials

HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC

Clinical trial NCT03869034 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03869034
Sponsor
Sun Yat-sen University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2019-03-25
Primary completion
2020-07-20
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.